SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 8.57 |
Enterprise Value ($M) | -3.09 |
Book Value ($M) | 15.11 |
Book Value / Share | 1.68 |
Price / Book | 0.57 |
NCAV ($M) | 11.04 |
NCAV / Share | 1.22 |
Price / NCAV | 0.78 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.65 |
Return on Assets (ROA) | -1.73 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.65 |
Current Ratio | 5.65 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 15.47 |
Assets | 19.54 |
Liabilities | 4.43 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.31 |
Operating Income | -14.66 |
Net Income | -11.26 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -13.72 |
Cash from Investing | 15.54 |
Cash from Financing | 7.82 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | FR Capital Holdings, L.P. | 3.02 | -73.79 | |
13G | B Capital Fund II, L.P. | 11.20 | ||
13D | Builders VC Fund I (Canada), L.P. | 25.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
7,883 | 16,772 | 47.00 | |
5,884 | 2,042 | 288.15 | |
10,320 | 4,189 | 246.36 | |
1,875 | 3,987 | 47.03 | |
1,958 | 7,333 | 26.70 | |
(click for more detail) |
Similar Companies | |
---|---|
NRBO – NeuroBo Pharmaceuticals, Inc. | NRSN – NeuroSense Therapeutics Ltd. |
NRXP – NRx Pharmaceuticals, Inc. | NVCT – Nuvectis Pharma, Inc. |
OCEA – Ocean Biomedical, Inc. |
Financial data and stock pages provided by
Fintel.io